MJoTA (Medical Journal of Therapeutics Africa)

MiMW (MJoTA Institute of Medical Writing) - Emerald Pademelon Press LLC - MJoTA-NYEcho Partners

MJoTA Portal

20120517 Coffee NEJM

20120517coffee alzheimers

20120517 Coffee Japan

20120104 NCHS twins

20120104 land of twins

20120194 Igbo twins

20120501 NIH asthma

20120501 Asthma US Africa

20120501 Asthma home

Dr Susanna website

Ganymede Movies LLP

Registration page

20111229 asd cdc

20111229 Autism video

20111229 MMWR

MJoTA.org resources 2011

Vaccinations

Diabetes

Diabetes CME resources

Diabetes Podcasts

Amer J Diabetes

Malaria

Malaria Podcasts

Liver

HIV/AIDS

HIV/AIDS Podcasts

BI HIV drug

CDC HIV

Cancer

Cancer Podcasts

Tuberculosis

Daily Updates

MiMW Certificate

MiMW

Calendar

MiMW Resources

MJoTAtalks: Health

MJoTA pages

Search page

MJoTA masthead

Author guidelines

MJoTA publications

Front covers

MJoTA 2011

MJoTA 2010

MJoTA 2009

MJoTA 2008

MJoTA 2007

MJoTA Mentors

homework Dec 09

MJoTA Presenting yourself

Job Fair

Regulatory doc files

Protocols

Indian drugs resources

Indian drug regulations

Kenya drug regs

Nigerian drug regs

Libya

Book concept to shelf

Health Audio Podcasts

Caribbean Health Podcasts

African Health Dialogues

African Health Podcasts

Child Health Podcasts

Contact us

Tropical diseases movies

 
Loading

USC Scientist Develops Virus That Targets HIV: Using a Virus to Kill a Virus

August 8, 2011. From University of South California press office. In what represents an important step toward curing HIV, a USC scientist has created a virus that hunts down HIV-infected cells.

Dr. Pin Wang's lentiviral vector latches onto HIV-infected cells, flagging them with what is called "suicide gene therapy" — allowing drugs to later target and destroy them.

"If you deplete all of the HIV-infected cells, you can at least partially solve the problem," said Wang, chemical engineering professor with the USC Viterbi School of Engineering.

The process is analogous to the military practice of "buddy lasing" — that is, having a soldier on the ground illuminate a target with a laser to guide a precision bombing strike from an aircraft.

Like a precision bombing raid, the lentiviral vector approach to targeting HIV has the advantage of avoiding collateral damage, keeping cells that are not infected by HIV out of harm's way. Such accuracy has not been achieved by using drugs alone, Wang said.

So far, the lentiviral vector has only been tested in culture dishes and has resulted in the destruction of about 35 percent of existing HIV cells. While that may not sound like a large percentage, if this treatment were to be used in humans, it would likely be repeated several times to maximize effectiveness.

Among the next steps will be to test the procedure in mice. While this is an important breakthrough, it is not yet a cure, Wang said.

"This is an early stage of research, but certainly it is one of the options in that direction," he said.

Wang's research, which was funded by the National Institutes of Health, appears in the July 23 issue of Virus Research.


MJoTA.org. Published since 2006 by Emerald Pademelon Press LLC. PO Box 381 Haddonfield, NJ 08033, USA. 1-609-792-1571. Publisher@mjota.org